Table 3.

Adjuvant systemic therapy decisions in a 1.6 cm grade 2 tumor according to nodal involvement and RS (majority vote shaded in gray)

Age	Nodal status	RS	Tamoxifen	OFS + TAM	OFS + AI	Chemo, then ET
47 years	N0	21	29%	22%	18%	24%
47 years	1/3 SLN	21	6%	17%	20%	57%
47 years	N0	17	46%	17%	27%	4%
47 years	1/3 SLN	17	6%	14%	32%	44%
47 years	N0	11	92%	2%	4%	0%
47 years	1/3 SLN	11	18%	23%	29%	29%
34 years	N0	21	4%	8%	26%	61%
34 years	1/3 SLN	21	0%	2.00%	6.00%	90.00%
34 years	N0	12	29%	25%	31%	15%

RS, recurrence score.